Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
26 January 2004 to 16 February 2004
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study under GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.2600 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
4-(butan-2-yloxy)-3,5-dimethoxybenzaldehyde
EC Number:
607-081-7
Cas Number:
224586-49-6
Molecular formula:
C13H18O4
IUPAC Name:
4-(butan-2-yloxy)-3,5-dimethoxybenzaldehyde
Test material form:
other: liquid
Details on test material:
- Name of test material (as cited in study report): v175023
- Physical state: brown liquid
- Analytical purity: 99.05%
- Lot/batch No.: v175023/P8B
- Expiration date of the lot/batch: 15 Dec 2004
- Storage condition of test material: at room temperature protected from light

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River France, L'Arbresle Cedex, France
- Age at study initiation: ca 11 weeks
- Weight at study initiation: 17-26 g
- Housing: individually in Macrolon cages (MI)
- Diet: pelleted laboratory animal diet ad libitum (Altromin (VRF1), Lage, Germany)
- Water: tap water ad libitum
- Acclimation period:> 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17.4-21.6°C
- Humidity (%): 26-68 %
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (LLNA)

Vehicle:
acetone/olive oil (4:1 v/v)
Remarks:
based on in-house trials
Concentration:
PIT: 100, 50, 25 and 10 %
Main: 100, 50, 10 and 0%
No. of animals per dose:
PIT: 1 female/dose
Main: 5 females/dose
Details on study design:
Preliminary Irritation Test: treatment on 2 consecutive days, ear was cleaned with tapwater 4 hours after last application
- Irritation: no irritation at any concentration
- Lymph node proliferation response: not measured

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: stimulation index >=3

TREATMENT PREPARATION AND ADMINISTRATION:
Epidermal induction on the dorsal ear (25 uL) for 3 consecutive days at 0 (vehicle), 10, 50 and 100%. On day 6 injection with radiolabelled thymidine. After ca 5 hours animals were killed, draining lymphnodes were excised, examined visually (size estimated) and pooled per animal in 3 mL PBS. Tissues were processed and radioactivity was assessed using a scintilliation counter.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
not performed

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Remarks on result:
other: see table
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: see table

Any other information on results incl. tables

 

Concentration (% v/v) in acetone/ olive oil 4:1

dpm /group

Stimulation Index

Result

Vehicle

 248 ± 119

1.0

 

10

 196 ± 252

0.8 ± 1.4

Negative

50

634 ± 465

2.6 ± 0.9

Negative

100

369 ± 259

1.5 ± 0.8

Negative

 

Mortality/clinical signs: none

Body weight: no effects

Irritation: no effects

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The substance is not sensitizing to the skin
Executive summary:

In a local lymphnode assay mice (3 females/treatment) received 3 daily applications of the substance at 0, 10, 50 and 100% at the dorsal site of the ear. After injection with radiolabelled thymidine, the SI was < 3 for all concentrations tested Therefore the substance is considered not sensitizing to the skin.